Julia Stingl at RWTH Aachen - Research Interests, Publications & Academic Profile

Julia Stingl

Professor

RWTH Aachen

Germany

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Bangladeshi students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacology

80%

Pharmacotherapy

100%

Pharmacometrics

40%

Drug Safety

40%

Medical Science

40%

Pharmacogenomic

40%

Emergency Medicine

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles18

Assessment of Substrate Status of Drugs Metabolized by Polymorphic Cytochrome P450 (CYP) 2 Enzymes: An Analysis of a Large-Scale Dataset

Article Link

Year:

2024

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Article Link

Year:

2023

Prevalence and determinants of over- and undertreatment among users of antihypertensive drugs in the general population: the Rhineland Study

Article Link

Year:

2023

The gradient model of brain organization in decisions involving "empathy for pain"

Article Link

Year:

2023

Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study

Article Link

Year:

2023

Inhalation therapies in COPD - adverse drug reactions impact on emergency department presentations

Article Link

Year:

2023

Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports

Article Link

Year:

2023

Comparative Investigation of Methods for Analysis of SARS-CoV-2-Spike-Specific Antisera

Article Link

Year:

2022

Inhalation therapies in COPD - adverse drug reactions impact on emergency department presentations.

Article Link

Year:

2022

Pharmacogenetic Dose Modeling Based on CYP2C19 Allelic Phenotypes

Article Link

Year:

2022

Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports.

Article Link

Year:

2022

Optimal@NRW: optimized acute care of nursing home residents using an intersectoral telemedical cooperation network - study protocol for a stepped-wedge trial.

Article Link

Year:

2022

Emergency Department Visits Due to Dyspnea: Association with Inhalation Therapy in COPD and Cases with Adverse Drug Reactions.

Article Link

Year:

2022

Pharmacogenetic and drug interaction aspects on ketamine safety in its use as antidepressant - implications for precision dosing in a global perspective.

Article Link

Year:

2022

Molecular Genetic Screening in Patients With ACE Inhibitor/Angiotensin Receptor Blocker-Induced Angioedema to Explore the Role of Hereditary Angioedema Genes.

Article Link

Year:

2022

Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer.

Article Link

Year:

2022

Green Tea Extract to Prevent Colorectal Adenomas, Results of a Randomized, Placebo-Controlled Clinical Trial.

Article Link

Year:

2022

Pharmacogenetic Dose Modeling Based on CYP2C19 Allelic Phenotypes

Article Link

Year:

2022

Collaborators8

Barbara Schnierle

Paul-Ehrlich-Institut

GERMANY

Marie-Luise Herrlein

Paul-Ehrlich-Institut

GERMANY

Albrecht Eisert

Assistent Professor

University Hospital

GERMANY

Roberto Viviani

University of Innsbruck

AUSTRIA

Panagiotis Ferentinos

Associate Professor of Psychiatry

National and Kapodistrian University of Athens - Faculty of Medicine

GREECE

Corinna Ernst

University of Cologne

GERMANY

Emilio Guirao-Arrabal

SPAIN

Kathrin Blagec

Medical University of Vienna

AUSTRIA

How do Bangladeshi students reach out?

Meet Kite AI